Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1277-1281

  Mullier, Francois ^a,b   Bailly, Nicolas ^a   Cornet, Yvan ^a   Dubuc, Eric ^a   Robert, Séverine ^b   Osselaer, Jean Claude ^a   Chatelain, Christian ^a   Dogné, Jean Michel ^b   Chatelain, Bernard ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; HEPARIN; IMMUNOGLOBULIN; LIPOCORTIN 5; THROMBOCYTE FACTOR 4; ANTIBODY; COAGULATING AGENT;

ADULT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LETTER; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; BLOOD; BLOOD CLOTTING PARAMETERS; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; FLOW CYTOMETRY; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; ORGANELLE SIZE; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

ANTIBODIES; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; COAGULANTS; FLOW CYTOMETRY; HEPARIN; HUMANS; ORGANELLE SIZE; PLATELET AGGREGATION; PLATELET FACTOR 4; PLATELET FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA;

EID: 77953175241     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-10-0711     Document Type: Letter

References (29)

1. Baroletti S, Piovella C, Fanikos J, et al. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thromb Haemost 2008; 100: 1130-1135.
2. Chong BH, Isaacs A. Heparin-induced thrombocytopenia: what clinicians need to know. Thromb Haemost 2009; 101: 279-283.
3. Greinacher A. Heparin-induced thrombocytopenia. J Thromb Haemost 2009; 7 (Suppl 1): 9-12.
4. Nowak G. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease. Thromb Haemost 2009; 102: 887-891.
5. Tardy-Poncet B, Piot M, Chapelle C, et al. Thrombin generation and heparin-induced thrombocytopenia. J Thromb Haemost 2009; 7: 1474-1481.
6. Hughes M, Hayward CP, Warkentin TE, et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-194. (Pubitemid 30456470)
7. Burnier L, Fontana P, Kwak BR, et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
8. Dean WL, Lee MJ, Cummins TD, et al. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009; 102: 711-718.
9. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscl Thromb Vasc Biol 2006; 26: 2594-2604.
10. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
11. Ueba T, Haze T, Sugiyama M, et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008; 100: 280-285.
12. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
13. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/ platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008; 100: 678-684.
14. Chong BH. Heparin-Induced Thrombocytopenia. In: Platelets. Elsevier Science; 2007; pp. 861-886.
15. Pouplard C, Amiral J, Borg JY, et al. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999; 111: 700-706. (Pubitemid 29200959)
16. Pouplard C, Amiral J, Borg JY, et al. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997; 99: 273-280. (Pubitemid 27497551)
17. Robert S, Poncelet P, Lacroix R, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009; 7: 190-197.
18. Dachary-Prigent J, Freyssinet JM, Pasquet JM, et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-2565. (Pubitemid 23147557)
19. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Seminars Thromb Haemost 2007; 33: 771-779.
20. Krueger LA, Barnard MR, Frelinger AL, 3rd, et al. Immunophenotypic analysis of platelets. Curr Protocols Cytometry 2002; Chapter 6:Unit 6 10.
21. Shah MD, Bergeron AL, Dong JF, et al. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008; 19: 365-372.
22. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008; 4: 769-774.
23. Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res 2008; 122 (Suppl 1): S47-54.
24. Adcock D. Sample integrity and preanalytical variables. In: Quality in Laboratory Hemostasis and Thrombosis. Wiley-Blackwell. 2009; pp. 31-42.
25. Enjeti AK, Lincz LF, Seldon M. Microparticles in health and disease. Seminars Thromb Haemost 2008; 34: 683-691.
26. Dignat-George F, Freyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets 2009; 20: 225-226; author reply 227-228.
27. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-1851.
28. Foladori P, Quaranta A, Ziglio G. Use of silica microspheres having refractive index similar to bacteria for conversion of flow cytometric forward light scatter into biovolume. Water Res 2008; 42: 3757-3766.
29. Koch L, Robertson B, Button D. Deduction of the cell volume and mass from the forward scatter intensity of bacteria analyzed by flow cytometry. J Microbiol Methods 1996; 27: 49-61.